Sepsis Slayer: Revolutionary Test Slashes Deaths by 39% in ER Breakthrough!
- Life-Saver: Cytovale's IntelliSep diagnostic cut sepsis deaths by an astounding 39% in a major real-world study.
- Speed is Key: Delivers critical sepsis risk assessment in under 10 minutes from a standard blood draw4, 5.
- ER Revolution: Empowers doctors to identify and triage high-risk sepsis patients faster, transforming emergency care.
In the frantic, high-stakes environment of the Emergency Department, sepsis has long been a shadowy, merciless killer. This elusive condition, more deadly than opioid overdoses, breast cancer, and prostate cancer combined6, often strikes silently, leaving clinicians in a desperate race against time. But now, a beacon of hope has emerged.
A landmark peer-reviewed study, published in the journal Healthcare and involving over 12,000 patients at Our Lady of the Lake Regional Medical Center, has unveiled the dramatic power of Cytovale's IntelliSep7, 8. This FDA-cleared rapid diagnostic didn't just chip away at sepsis mortality; it delivered a staggering 39% relative reduction in deaths7, 8. "This is the kind of data the medical field has been waiting for... a breakthrough in sepsis care," declared the study author, Vice President and Chief Quality Officer at Franciscan Missionaries of Our Lady Health System.
IntelliSep is not just another test; it's a paradigm shift. Utilizing cutting-edge deformability cytometry to examine white blood cell dysregulation at a single-cell level4, 5, it provides results in approximately eight minutes. This allows clinicians to categorize patients by their probability of sepsis even before full clinical signs manifest, giving them unprecedented confidence to act decisively5. The study also highlighted a shortened hospital stay by an average of 0.76 days and more efficient resource allocation in the ED7, 8.
"For decades, we've lacked a fast, reliable way to catch sepsis early," stated the Medical Director of Research at OLOLRMC. "This study proves that with speed, objectivity and accuracy at the point of triage, we can change outcomes before antibiotics are given or ICU beds are needed. That's where real transformation begins." This "game-changing model" is more than an innovation; it's a new dawn in the fight against one of medicine's deadliest foes.
References
Stay Updated!
Get the latest biotech and pharma news delivered to your inbox.